Deep Track Capital, Lp Top Holdings and 13F Report (2024) → Trump conviction scandal exposed (From Porter & Company) (Ad) About Deep Track Capital, LpInvestment ActivityDeep Track Capital, Lp has $3.49 billion in total holdings as of March 31, 2024.Deep Track Capital, Lp owns shares of 65 different stocks, but just 29 companies or ETFs make up 80% of its holdings.Approximately 29.03% of the portfolio was purchased this quarter.About 19.02% of the portfolio was sold this quarter.This quarter, Deep Track Capital, Lp has purchased 58 new stocks and bought additional shares in 14 stocks.Deep Track Capital, Lp sold shares of 16 stocks and completely divested from 12 stocks this quarter.Largest Holdings SpringWorks Therapeutics $171,278,365Amgen $156,376,000APOGEE THERAPEUTICS INC $154,393,651Insmed $129,781,211DYNE THERAPEUTICS INC $129,327,323 Largest New Holdings this Quarter Amgen $156,376,000 HoldingAlnylam Pharmaceuticals $124,388,730 HoldingMind Medicine (MindMed) $62,666,670 HoldingApellis Pharmaceuticals $58,780,000 HoldingKymera Therapeutics $50,742,289 Holding Largest Purchases this Quarter Amgen 550,000 shares (about $156.38M)Alnylam Pharmaceuticals 832,310 shares (about $124.39M)DYNE THERAPEUTICS INC 2,555,383 shares (about $72.55M)Mind Medicine (MindMed) 6,666,667 shares (about $62.67M)Apellis Pharmaceuticals 1,000,000 shares (about $58.78M) Largest Sales this Quarter AnaptysBio 1,507,538 shares (about $33.95M)SpringWorks Therapeutics 583,823 shares (about $28.74M)SPYRE THERAPEUTICS INC 739,340 shares (about $28.04M)Intra-Cellular Therapies 324,600 shares (about $22.46M)Immunovant 506,648 shares (about $16.37M) Sector Allocation Over TimeMap of 500 Largest Holdings ofDeep Track Capital, Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorSWTXSpringWorks Therapeutics$171,278,365$28,735,768 ▼-14.4%3,479,8534.9%MedicalAMGNAmgen$156,376,000$156,376,000 ▲New Holding550,0004.5%MedicalAPOGEE THERAPEUTICS INC$154,393,6510.0%2,323,4564.4%COMINSMInsmed$129,781,211$15,364,289 ▼-10.6%4,783,6793.7%MedicalDYNE THERAPEUTICS INC$129,327,323$72,547,323 ▲127.8%4,555,3833.7%COMALNYAlnylam Pharmaceuticals$124,388,730$124,388,730 ▲New Holding832,3103.6%MedicalGHGuardant Health$123,780,000$20,630,000 ▲20.0%6,000,0003.5%MedicalARGXargenx$118,116,0000.0%300,0003.4%MedicalITCIIntra-Cellular Therapies$115,937,680$22,462,320 ▼-16.2%1,675,4003.3%MedicalNTLAIntellia Therapeutics$115,838,668$53,941,168 ▲87.1%4,210,7843.3%MedicalOCULOcular Therapeutix$115,765,286$31,765,288 ▲37.8%12,721,4603.3%MedicalDVAXDynavax Technologies$113,448,001$25,421,215 ▲28.9%9,141,6603.2%MedicalAXSMAxsome Therapeutics$104,116,736$24,316,736 ▲30.5%1,304,7213.0%MedicalGERNGeron$100,669,566$3,044,184 ▲3.1%30,505,9292.9%MedicalAUTLAutolus Therapeutics$97,436,457$21,710,342 ▲28.7%15,272,1722.8%MedicalFDMT4D Molecular Therapeutics$96,677,673$23,897,581 ▲32.8%3,034,4532.8%MedicalALKSAlkermes$94,745,000$13,535,000 ▼-12.5%3,500,0002.7%MedicalBCYCBicycle Therapeutics$86,913,5990.0%3,490,5062.5%MedicalPLRXPliant Therapeutics$85,675,0000.0%5,750,0002.5%MedicalMNMDMind Medicine (MindMed)$62,666,670$62,666,670 ▲New Holding6,666,6671.8%MedicalABIVAX SA$61,453,3630.0%4,297,4381.8%SPONSORED ADSVRDNViridian Therapeutics$60,515,488$3,076,069 ▼-4.8%3,456,0531.7%MedicalIONSIonis Pharmaceuticals$59,540,141$5,393,043 ▲10.0%1,373,4751.7%MedicalAPLSApellis Pharmaceuticals$58,780,000$58,780,000 ▲New Holding1,000,0001.7%MedicalANIPANI Pharmaceuticals$56,824,929$15,346,929 ▲37.0%822,0011.6%MedicalTVTXTravere Therapeutics$56,822,7000.0%7,370,0001.6%MedicalVRNAVerona Pharma$51,285,5070.0%3,187,4151.5%MedicalKYMRKymera Therapeutics$50,742,289$50,742,289 ▲New Holding1,262,2461.5%MedicalIVVDInvivyd$48,635,480$48,635,480 ▲New Holding10,953,9371.4%MedicalSPYRE THERAPEUTICS INC$46,025,021$28,043,166 ▼-37.9%1,213,4201.3%COM NEWNRIXNurix Therapeutics$44,068,1010.0%2,997,8301.3%MedicalHLVXHilleVax$42,780,010$5,446,990 ▼-11.3%2,572,4601.2%MedicalEDITEditas Medicine$41,012,492$402,194 ▲1.0%5,527,2901.2%MedicalFATEFate Therapeutics$40,902,935$40,902,935 ▲New Holding5,572,6071.2%MedicalTERNTerns Pharmaceuticals$40,016,0000.0%6,100,0001.1%MedicalENGENE HOLDINGS INC$38,137,500$38,137,500 ▲New Holding2,250,0001.1%COMTOURMALINE BIO INC$36,534,660$5,048,397 ▼-12.1%1,595,4001.0%COMOLMAOlema Pharmaceuticals$36,511,743$14,654,023 ▲67.0%3,225,4191.0%MedicalSLNSilence Therapeutics$35,507,830$6,646,298 ▼-15.8%1,643,8811.0%MedicalPACBPacific Biosciences of California$26,250,0000.0%7,000,0000.8%MedicalCYBNCybin$24,040,698$24,040,698 ▲New Holding58,139,5350.7%MedicalALECAlector$22,691,704$22,691,704 ▲New Holding3,769,3860.6%MedicalNUVLNuvalent$20,613,106$13,177,394 ▼-39.0%274,5120.6%MedicalAGENAgenus$18,384,5730.0%31,697,5390.5%MedicalPYXSPyxis Oncology$17,824,266$17,824,266 ▲New Holding4,184,1000.5%MedicalNKTRNektar Therapeutics$17,189,2800.0%18,400,0000.5%MedicalIMVTImmunovant$15,940,203$16,369,797 ▼-50.7%493,3520.5%MedicalNEUMORA THERAPEUTICS INC.$13,750,000$13,750,000 ▲New Holding1,000,0000.4%COMRPTXRepare Therapeutics$12,643,260$1,452,503 ▼-10.3%2,684,3440.4%MedicalSRRKScholar Rock$12,076,800$5,893,283 ▼-32.8%680,0000.3%MedicalANABAnaptysBio$11,923,259$33,949,756 ▼-74.0%529,4520.3%MedicalRGLSRegulus Therapeutics$9,407,710$9,407,710 ▲New Holding3,266,5660.3%MedicalALTO NEUROSCIENCE INC$9,210,000$9,210,000 ▲New Holding600,0000.3%COM SHSRAREUltragenyx Pharmaceutical$7,833,835$7,833,835 ▲New Holding167,7840.2%MedicalZURAZura Bio$6,484,1100.0%2,523,0000.2%MedicalALLKAllakos$6,300,000$3,136,473 ▲99.1%5,000,0000.2%MedicalALGSAligos Therapeutics$5,980,7150.0%6,102,7700.2%MedicalRLMDRelmada Therapeutics$5,766,158$3,740,799 ▼-39.3%1,240,0340.2%MedicalVIGLVigil Neuroscience$5,438,7150.0%1,594,9310.2%MedicalMETAGENOMI INC$4,918,748$4,918,748 ▲New Holding466,2320.1%COMSYRSSyros Pharmaceuticals$4,432,3950.0%828,4850.1%MedicalMRSNMersana Therapeutics$2,596,940$2,596,940 ▲New Holding579,6740.1%MedicalPRMEPrime Medicine$2,126,012$2,126,012 ▲New Holding303,7160.1%MedicalCOGTCogent Biosciences$2,123,520$2,123,520 ▲New Holding316,0000.1%MedicalGPCRStructure Therapeutics$1,720,272$11,137,729 ▼-86.6%40,1370.0%MedicalCYTKCytokinetics$0$136,610,429 ▼-100.0%00.0%MedicalAMBRX BIOPHARMA INC$0$52,836,267 ▼-100.0%00.0%COMSRPTSarepta Therapeutics$0$48,215,000 ▼-100.0%00.0%MedicalRAPTRAPT Therapeutics$0$44,580,055 ▼-100.0%00.0%MedicalACLXArcellx$0$40,245,548 ▼-100.0%00.0%MedicalORTXOrchard Therapeutics$0$33,585,472 ▼-100.0%00.0%MedicalEWTXEdgewise Therapeutics$0$27,756,705 ▼-100.0%00.0%MedicalPRTAProthena$0$27,255,000 ▼-100.0%00.0%MedicalAGIOAgios Pharmaceuticals$0$23,670,360 ▼-100.0%00.0%MedicalPTGXProtagonist Therapeutics$0$6,310,359 ▼-100.0%00.0%MedicalJAZZJazz Pharmaceuticals$0$5,938,440 ▼-100.0%00.0%MedicalGHRSGH Research$0$2,896,520 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data: SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
